Ultragenyx Pharmaceutical (RARE) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -8.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.40% |
| Dec 31, 2025 | -8.27% |
| Sep 30, 2025 | -8.25% |
| Jun 30, 2025 | -8.23% |
| Mar 31, 2025 | -8.49% |
| Dec 31, 2024 | -8.45% |
| Sep 30, 2024 | -8.21% |
| Jun 30, 2024 | -3.56% |
| Mar 31, 2024 | 2.60% |
| Dec 31, 2023 | 11.87% |
| Sep 30, 2023 | 26.51% |
| Jun 30, 2023 | 39.35% |
| Mar 31, 2023 | 56.93% |
| Dec 31, 2022 | 83.88% |
| Sep 30, 2022 | 97.04% |
| Jun 30, 2022 | 98.32% |
| Mar 31, 2022 | 102.21% |
| Dec 31, 2021 | 92.13% |
| Sep 30, 2021 | 144.13% |
| Mar 31, 2021 | 83.99% |
| Dec 31, 2020 | 65.77% |
| Sep 30, 2020 | 53.00% |
| Mar 31, 2020 | 119.38% |
| Dec 31, 2019 | 121.23% |
| Sep 30, 2019 | 60.77% |
| Jun 30, 2019 | 21.38% |
| Mar 31, 2019 | 4.16% |
| Dec 31, 2018 | -8.20% |
| Sep 30, 2018 | 23.69% |
| Jun 30, 2018 | 27.14% |
| Mar 31, 2018 | 26.11% |
| Dec 31, 2017 | 28.04% |
| Sep 30, 2017 | -12.05% |
| Jun 30, 2017 | -3.81% |
| Mar 31, 2017 | 23.10% |
| Dec 31, 2016 | 131.32% |
| Sep 30, 2016 | 189.99% |
| Jun 30, 2016 | 257.38% |
| Mar 31, 2016 | 281.84% |
| Dec 31, 2015 | 143.09% |
| Sep 30, 2015 | 139.79% |
| Jun 30, 2015 | 91.11% |
| Mar 31, 2015 | 97.75% |
| Dec 31, 2014 | 128.91% |